Scott Kathleen D.
- SEC CIK
- 0001794284
In the past year, 1 open-market sale filing worth $13.09 and no purchases.
Current role at each company
- DRMA Dermata Therapeutics, Inc.Directoras of Jun 16, 2026
- SPRY ARS Pharmaceuticals, Inc.Chief Financial Officeras of Jan 5, 2026
- NKGN NKGen Biotech, Inc.Directoras of Dec 10, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $13.09
- 1 filing
- Net
- −$13.09
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Scott Kathleen D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DRMA Dermata Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 (view filing) | Jun 16 | Same day | Scott Kathleen D.Director | SSale | −11 | $1.19 | −$13.09 | −100.0%0 after |
SPRY ARS Pharmaceuticals, Inc.
Chief Financial Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 (view filing) | Aug 21 | 1 day | Scott Kathleen D.Chief Financial Officer | SSale | −12.5K | $15.00 | −$187.5K | −55.5%10.0K after | 10b5-1 |
| May 22, 2025 (view filing) | May 20 | 2 days | Scott Kathleen D.Chief Financial Officer | SSale | −50.0K | $14.10 | −$705.0K | −87.1%7.42K after | |
| Oct 17, 2024 (view filing) | Oct 16 | 1 day | Scott Kathleen D.Chief Financial Officer | SSale | −12.5K | $16.00 | −$200.0K | −71.6%4.95K after | 10b5-1 |
| Aug 21, 2024 (view filing) | Aug 20 | 1 day | Scott Kathleen D.Chief Financial Officer | SSale | −12.5K | $16.00 | −$200.0K | −48.6%13.2K after | 10b5-1 |
| Dec 1, 2022 (view filing) | Nov 29 | 2 days | Scott Kathleen D.Chief Financial Officer | PPurchase | +8.25K | $6.24 | +$51.5K | New position8.25K after |